Biotech Values

[io_io]

Dew or anyone .......re: GTCB

I went back again to the Read-Me-First on GTCB, and now I see that when I printed this article on GTCB's Atryn history, somehow I only ended up with 1 page in my records. This answers some of my questions.

Going back to 98/99/00 - can we read between the lines exactly why GTCB failed with the heparin-resistant population ? It is not exactly clear why - was it really the need for more trials ? - I don't think so. Was it then the side-effects, given that the inidcation was not too high-risk ? Or is this population still in their gun-sights ?

TiA